ストックスクリーナーアプリを入手
4.03
2.90%
-0.1205
Imagenebio Inc (IMA) 最新ニュース
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Three new hires receive ImageneBio stock awards; options let them buy shares for $4.58 - Stock Titan
ImageneBio, Inc. (NASDAQ: IMA) Share Price, IMA Stock News, IMA Share Price & Updates - kalkine.com.au
ImageneBio, Inc.Common Stock (Nasdaq:IMA) Detailed Stock Data - The Chronicle-Journal
ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York - The Manila Times
A biotech CEO will speak in New York. ImageneBio will archive the webcast for 90 days. - Stock Titan
IMA Q2 2026 Earnings: Narrower EPS Loss Beats Estimates, Shares Slip 6.4%Earnings Call Highlights - vinanet.vn
ImageneBio (IMA) Edges Higher to $5.34 as Bulls Defend Key SupportPost-Earnings Moves - vinanet.vn
ImageneBio (IMA) Edges Higher to $5.34 as Bulls Defend Key SupportVol Target Rebalance - dars.gov.et
ImageneBio (IMA) Market: Finishes 1.78% Lower at $5.51 in the Current Update; Technical View: the Price Remains Bounded by the Supplied Support and Resistance on the DayCorrective Wave - vinanet.vn
ImageneBio (IMA) Market: Finishes 1.78% Lower at $5.51 in the Current Update; Technical View: the Price Remains Bounded by the Supplied Support and Resistance on the DayIV Crush Alert - dars.gov.et
ImageneBio, Inc. (NASDAQ:IMA) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
HC Wainwright Initiates ImageneBio at Buy With $28 Price Target - marketscreener.com
Blue Owl Capital Holdings LP Invests $5.41 Million in ImageneBio, Inc. $IMA - MarketBeat
ImageneBio (NASDAQ:IMA) Trading 1.8% HigherWhat's Next? - MarketBeat
ImageneBio Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
ImageneBio (IMA) shifts CFO equity mix toward RSUs in new grant - Stock Titan
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Caledonian Record
ImageneBio's New Hires Get Stock Awards as CFO Gets a Separate Award - Stock Titan
ImageneBio, Inc. (IMA): BVF group discloses 9.99% stake and large warrants - Stock Titan
ImageneBio, Inc. (NASDAQ: IMA) Share Price, IMA Stock News, IMA Share Price & Updates - kalkine.ca
ImageneBio, Inc. SEC Filing (Aug 12, 2026) - Stock Titan
ImageneBio, Inc. SEC Filing (Aug 12, 2026) - Stock Titan
ImageneBio Ord Shs (IMA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ImageneBio, Inc. SEC Filing (Aug 7, 2026) - Stock Titan
Wedbush Maintains ImageneBio(IMA.US) With Sell Rating, Maintains Target Price $2 - Moomoo
William Blair Maintains ImageneBio(IMA.US) With Buy Rating - Moomoo
ImageneBio (IMA) registers 1.37M existing shares for resale on Form S-3 - Stock Titan
ImageneBio (IMA) sets up $200M shelf and $17M ATM stock program - Stock Titan
ImageneBio (IMA) files to register 5.77M warrant shares for investor resale - Stock Titan
ImageneBio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
ImageneBio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
ImageneBio Sees Cash Runway Funding Planned Ops Into 1Q of 2028 >IMA - Moomoo
ImageneBio, Inc. Q2 2026: Revenue $0 EPS $(0.63) — 10-Q Summary - TradingView
ImageneBio Reports Second Quarter 2026 Financial Results - The Manila Times
ImageneBio Reports Second Quarter 2026 Financial Results and Corporate Update on Olevaprubart Clinical Development - Quiver Quantitative
ImageneBio reports Q2 2026: $136.2M cash; $10.2M net loss for quarter - TradingView
ImageneBio Posts $10.2 Million Q2 Loss With Cash Runway Into 2028 - Quiver Quantitative
ImageneBio (Nasdaq: IMA) details Q2 2026 loss and $136M cash runway - Stock Titan
IMA: Clinical pipeline advances and robust cash position support continued development through 2028 - TradingView
ImageneBio Sees Cash Runway Funding Planned Ops Into 1Q of 2028 >IMA - Moomoo
ImageneBio’s Atopic Dermatitis Data Anticipated in Q4 2027 - Stock Titan
ImageneBio Posts $10.2 Million Q2 Loss With Cash Runway Into 2028 - Quiver Quantitative
IKNA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
IMA Q2'26 Earnings: revenue estimate is 0 USD - TradingView
ImageneBio, Inc. Revenue Breakdown – NASDAQ:IMA - TradingView
ImageneBio Inc. (IMA) Q1 2026 Earnings: EPS Miss Highlights Pre‑Revenue Challenges as Stock Rises - dars.gov.et
ImageneBio Inc. (IMA) Q1 2026 Earnings: EPS Miss Highlights Pre‑Revenue Challenges as Stock Rises - dars.gov.et
1.35%
大文字化:
|
ボリューム (24 時間):